
Investment Opportunities in Singapore’s Biopharma Sector
Singapore has rapidly established itself as a leading biopharmaceutical hub in Asia, attracting global giants and pioneering startups with its innovation-focused ecosystem. In 2024 alone, Singapore secured S$13.5 billion in fixed asset investment …